Article Correctness Is Author's Responsibility: Kidney Cancer Study Uncovers New Subtypes and Clues to Better Diagnosis and Treatment

Newswise imageIn what is believed to be the most comprehensive molecular characterization to date of the most common -- and often treatment-resistant -- form of kidney cancer, researchers at Johns Hopkins' departments of pathology and oncology, Johns Hopkins Kimmel Cancer Center, and the Johns Hopkins University School of Medicine report evidence for at least three distinct subtypes of clear cell renal cell carcinoma (ccRCC), along with new revelations about the proteins that define them. Their findings could inform overall patient survival and response to treatment.